The DOI matches its Crossref record; 58 of the 58 references it cites were found in a registry or an index.
Amyloid β-peptide (1-42)-induced Oxidative Stress and Neurotoxicity: Implications for Neurodegeneration in Alzheimer's Disease Brain. A Review
Abstract
Oxidative stress, manifested by protein oxidation, lipid peroxidation, DNA oxidation and 3-nitrotyrosine formation, among other indices, is observed in Alzheimer's disease (AD) brain. Amyloid beta-peptide (1-42) [Abeta(1-42)] may be central to the pathogenesis of AD. Our laboratory and others have implicated Abeta(1-42)-induced free radical oxidative stress in the neurodegeneration observed in AD brain. This paper reviews some of these studies from our laboratory. Recently, we showed both in-vitro and in-vivo that methionine residue 35 (Met-35) of Abeta(1-42) was critical to its oxidative stress and neurotoxic properties. Because the C-terminal region of Abeta(1-42) is helical, and invoking the i + 4 rule of helices, we hypothesized that the carboxyl oxygen of lle-31, known to be within a van der Waals distance of the S atom of Met-35, would interact with the latter. This interaction could alter the susceptibility for oxidation of Met-35, i.e. free radical formation. Consistent with this hypothesis, substitution of lle-31 by the helix-breaking amino acid, proline, completely abrogated the oxidative stress and neurotoxic properties of Abeta(1-42). Removal of the Met-35 residue from the lipid bilayer by substitution of the negatively charged Asp for Gly-37 abrogated oxidative stress and neurotoxic properties of Abeta(1-42). The free radical scavenger vitamin E prevented A(beta (1-42)-induced ROS formation, protein oxidation, lipid peroxidation, and neurotoxicity in hippocampal neurons, consistent with our model for Abeta-associated free radical oxidative stress induced neurodegeneration in AD. ApoE, allele 4, is a risk factor for AD. Synaptosomes from apoE knock-out mice are more vulnerable to Abeta-induced oxidative stress (protein oxidation, lipid peroxidation, and ROS generation) than are those from wild-type mice. We also studied synaptosomes from allele-specific human apoE knock-in mice. Brain membranes from human apoE4 mice have greater vulnerability to Abeta(1-42)-induced oxidative stress than brain membranes from apoE2 or E3, assessed by the same indices, consistent with the notion of a coupling of the oxidative environment in AD brain and increased risk of developing this disorder. Using immunoprecipitation of proteins from AD and control brain obtained no longer than 4h PMI, selective oxidized proteins were identified in the AD brain. Creatine kinase (CK) and beta-actin have increased carbonyl groups, an index of protein oxidation, and Glt-1, the principal glutamate transporter, has increased binding of the lipid peroxidation product, 4-hydroxy-2-nonenal (HNE). Abeta inhibits CK and causes lipid peroxidation, leading to HNE formation. Implications of these findings relate to decreased energy utilization, altered assembly of cytoskeletal proteins, and increased excitotoxicity to neurons by glutamate, all reported for AD. Other oxidatively modified proteins have been identified in AD brain by proteomics analysis, and these oxidatively-modified proteins may be related to increased excitotoxicity (glutamine synthetase), aberrant proteasomal degradation of damaged or aggregated proteins (ubiquitin C-terminal hydrolase L-1), altered energy production (alpha-enolase), and diminished growth cone elongation and directionality (dihydropyrimindase-related protein 2). Taken together, these studies outlined above suggest that Met-35 is key to the oxidative stress and neurotoxic properties of Abeta(1-42) and may help explain the apoE allele dependence on risk for AD, some of the functional and structural alterations in AD brain, and strongly support a causative role of Abeta(1-42)-induced oxidative stress and neurodegeneration in AD.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Oxidative stress and mitochondrial dysfunction are prominent features of many neurodegenerative diseases including AD (Butterfield, 2002; Butterfield and Boyd-Kimball, 2018; Sharma and Kim, 2021).”
From Exploring the Therapeutic Potential of Phytochemicals in Alzheimer’s Disease: Focus on Polyphenols and Monoterpenes (2022) · cites this paper as Butterfield, 2002
In the citing paper
“For the same reason, the Aβ insertion into the lipid bilayer of the neuronal plasma membrane induces lipid peroxidation in a direct manner (Butterfield, 2002).”
From Exploring the Therapeutic Potential of Phytochemicals in Alzheimer’s Disease: Focus on Polyphenols and Monoterpenes (2022) · cites this paper as Butterfield, 2002
Citations
Cites
Free radicals in biology and medicine
Gutteridge, J. M. C. (1991) · General Pharmacology The Vascular System · doi:10.1016/0306-3623(91)90478-o · Cited by 17,178
Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes
Esterbauer, H., Schaur, R. J., & Zollner, H. (1991) · Free Radical Biology and Medicine · doi:10.1016/0891-5849(91)90192-6 · Cited by 6,672
Walsh, D. M., Klyubin, I., Fadeeva, J. V., Cullen, W. K., Anwyl, R., Wolfe, M. S., Rowan, M. J., & Selkoe, D. J. (2002) · Nature · doi:10.1038/416535a · Cited by 4,291
Apolipoprotein E: Cholesterol Transport Protein with Expanding Role in Cell Biology
Mahley, R. W. (1988) · Science · doi:10.1126/science.3283935 · Cited by 4,028
Oxidative stress hypothesis in Alzheimer’s disease
Markesbery, W. R. (1997) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(96)00629-6 · Cited by 2,383
Excess brain protein oxidation and enzyme dysfunction in normal aging and in Alzheimer disease.
Smith, C. D., Carney, J. M., Starke-Reed, P. E., Oliver, C. N., Stadtman, E. R., Floyd, R. A., & Markesbery, W. R. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.23.10540 · Cited by 1,296
Amyloid β-Protein Fibrillogenesis
Walsh, D. M., Hartley, D. M., Kusumoto, Y., Fezoui, Y., Condron, M. M., Lomakin, A., Benedek, G. B., Selkoe, D. J., & Teplow, D. B. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.36.25945 · Cited by 1,046
Butterfield, D. A., & Lauderback, C. M. (2002) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(02)00794-3 · Cited by 1,013
Impaired Proteasome Function in Alzheimer's Disease
Keller, J. N., Hanni, K. B., & Markesbery, W. R. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.0750436.x · Cited by 848
Mark, R. J., Lovell, M. A., Markesbery, W. R., Uchida, K., & Mattson, M. P. (1997) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1997.68010255.x · Cited by 781
Cited by
Sorted by citations
Items 301–400 of 794
Swedish amyloid precursor protein mutation increases phosphorylation of eIF2α in vitro and in vivo
Kim, H., Choi, Y., Shin, K. Y., Joo, Y., Lee, Y., Jung, S. Y., Suh, Y., & Kim, J. (2007) · Journal of Neuroscience Research · doi:10.1002/jnr.21267 · Cited by 49
Chiang, M., Nicol, C. J. B., Cheng, Y., Lin, K., Yen, C., & Lin, C. (2016) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2016.01.132 · Cited by 52
Amyloid-beta and tau proteins as biochemical markers of Alzheimer's disease
Sobów, T., Flirski, M., & Liberski, P. P. (2004) · Acta Neurobiologiae Experimentalis · doi:10.55782/ane-2004-1491 · Cited by 53
Proteomics‐driven progress in neurodegeneration research
Fountoulakis, M., & Κοσσίδα, Σ. (2006) · Electrophoresis · doi:10.1002/elps.200500738 · Cited by 52
Zhang, J., Feng, X., Wu, J., Xu, H., Li, G., Zhu, D., Yue, Q., Liu, H., Zhang, Y., Sun, D., et al. (2014) · BioFactors · doi:10.1002/biof.1149 · Cited by 50
Seo, J., Lee, K.-W., Kim, T., Baek, I., Im, J., & Han, P. (2011) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2011.02.035 · Cited by 51
Prasad, K. N., & Bondy, S. C. (2014) · Brain Research · doi:10.1016/j.brainres.2014.12.038 · Cited by 54
Amyloid β-induced erythrocytic damage and its attenuation by carotenoids
Nakagawa, K., Kiko, T., Miyazawa, T., Sookwong, P., Tsuduki, T., Satoh, A., & Miyazawa, T. (2011) · FEBS Letters · doi:10.1016/j.febslet.2011.03.060 · Cited by 51
Jalsrai, A., Liu, Z., Long, J., Mo, X., Ma, J., & Liu, J. (2009) · Neurochemical Research · doi:10.1007/s11064-009-0027-4 · Cited by 50
miR-302 Attenuates Amyloid-β-Induced Neurotoxicity through Activation of Akt Signaling
Li, H., Lin, S.-L., Huang, C., Lu, F., Chiu, P., Huang, W., Lai, T., & Lin, C. (2016) · Journal of Alzheimer s Disease · doi:10.3233/jad-150741 · Cited by 50
Nanoceria: Synthesis and Biomedical Applications
Sahu, T., Bisht, S. S., Das, K. R., & Kerkar, S. (2013) · Current Nanoscience · doi:10.2174/15734137113099990084 · Cited by 50
Fibroblast glutamate transport in aging and in AD: correlations with disease severity
Zoia, C., Tagliabue, E., Isella, V., Begni, B., Fumagalli, L., Brighina, L., Appollonio, I. M., Racchi, M., & Ferrarese, C. (2004) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2004.07.007 · Cited by 50
Daulatzai, M. A. (2012) · Neurochemical Research · doi:10.1007/s11064-011-0680-2 · Cited by 49
Ahn, J., Um, M. Y., Choi, W., Kim, S., & Ha, T. Y. (2006) · Biogerontology · doi:10.1007/s10522-006-9023-0 · Cited by 50
da Silva, G. F. Z., & Ming, L. (2007) · Angewandte Chemie International Edition · doi:10.1002/anie.200604421 · Cited by 50
Debra Boyd-kimball, A., Rukhsana Sultana, A., Poon, H. F., Abdul, H. M., Lynn, B. C., Klein, J. B., & Butterfield, D. A. (2005) · Journal of Neuroscience Research · doi:10.1002/jnr.20393 · Cited by 50
Targeting NADPH Oxidase and Phospholipases A2 in Alzheimer’s Disease
Simonyi, Á., He, Y., Sheng, W., Sun, A. Y., Wood, W. G., Weisman, G. A., & Sun, G. Y. (2010) · Molecular Neurobiology · doi:10.1007/s12035-010-8107-7 · Cited by 51
Rohn, T. T. (2013) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2013/860959 · Cited by 51
Interaction of amyloid β peptides with redox active heme cofactor: Relevance to Alzheimer's disease
Pramanik, D., Ghosh, C., Mukherjee, S., & Dey, S. G. (2012) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2012.02.025 · Cited by 50
Amyloid β Peptide Conformational Changes in the Presence of a Lipid Membrane System
Accardo, A., Shalabaeva, V., Cotte, M., Burghammer, M. C., Krahne, R., Riekel, C., & Dante, S. (2014) · Langmuir · doi:10.1021/la500145r · Cited by 49
Tanemura, K., Chui, D.-H., Fukuda, T., Murayama, M., Park, J.-M., Akagi, T., Tatebayashi, Y., Miyasaka, T., Kimura, T., Hashikawa, T., et al. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m509145200 · Cited by 48
Goto, Y., Niidome, T., Akaike, A., Kihara, T., & Sugimoto, H. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.10.030 · Cited by 49
Cerebrometabolic abnormalities in Alzheimer's disease
Blass, J. P. (2003) · Neurological Research · doi:10.1179/016164103101201995 · Cited by 49
Dihydroxybenzoic acids as free radical scavengers: mechanisms, kinetics, and trends in activity
Pérez‐González, A., Galano, A., & Alvarez-Idaboy, J. R. (2014) · New Journal of Chemistry · doi:10.1039/c4nj00071d · Cited by 48
Synthesis and biological evaluation of new spirooxindoles with embedded pharmacophores
Mathusalini, S., Arasakumar, T., Lakshmi, K., Lin, C., Mohan, P. S., Ramnath, M. G., & Thirugnanasampandan, R. (2016) · New Journal of Chemistry · doi:10.1039/c6nj00534a · Cited by 48
Gururaj Joshi, A., Rukhsana Sultana, A., Marzia Perluigi, A., & Butterfield, D. A. (2005) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2004.12.027 · Cited by 48
Increased susceptibility to amyloid toxicity in familial Alzheimer's fibroblasts
Cecchi, C., Fiorillo, C., Baglioni, S., Pensalfini, A., Bagnoli, S., Nacmias, B., Sorbi, S., Nosi, D., Relini, A., & Liguri, G. (2006) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2006.05.014 · Cited by 48
Vorobyov, V., Kaptsov, V., Gordon, R. Y., Makarova, E. G., Podolski, I. Y., & Sengpiel, F. (2015) · Journal of Alzheimer s Disease · doi:10.3233/jad-142469 · Cited by 47
New Markers of Oxidative Damage to Macromolecules
Čolak, E. (2008) · Journal of Medical Biochemistry · doi:10.2478/v10011-007-0049-x · Cited by 47
Liu, B., Gu, Y., Xiao, H., Lei, X., Liang, W., & Zhang, J. (2015) · Neurochemical Research · doi:10.1007/s11064-015-1529-x · Cited by 47
Galano, A., León‐Carmona, J. R., & Alvarez-Idaboy, J. R. (2012) · The Journal of Physical Chemistry B · doi:10.1021/jp302810w · Cited by 49
Bromfield, E. G., Aitken, R. J., McLaughlin, E. A., & Nixon, B. (2016) · Molecular Human Reproduction · doi:10.1093/molehr/gaw074 · Cited by 47
Sehgal, S. A., Hammad, M. A., Tahir, R. A., Akram, H. N., & Ahmad, F. (2018) · Current Neuropharmacology · doi:10.2174/1570159x16666180315142137 · Cited by 47
Han, Q., Wang, X., Liu, X., Zhang, Y., Cai, S., Cui, Q., Wang, C., & Yang, R. (2018) · Journal of Colloid and Interface Science · doi:10.1016/j.jcis.2018.12.093 · Cited by 46
Transition metal complexes as imaging or therapeutic agents for neurodegenerative diseases
Ma, D., Wu, C., Li, G., Yung, T.-L., & Leung, C. (2020) · Journal of Materials Chemistry B · doi:10.1039/c9tb02669j · Cited by 47
Cecarini, V., Bonfili, L., Gogoi, O., Lawrence, S., Venanzi, F. M., Azevedo, V., Mancha-Agresti, P. D. C., Drumond, M. M., Rossi, G., Berardi, S., et al. (2020) · Aging · doi:10.18632/aging.103900 · Cited by 49
Despite its role in assembly, methionine 35 is not necessary for amyloid β‐protein toxicity
Maiti, P., Lomakin, A., Benedek, G. B., & Bitan, G. (2010) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2010.06692.x · Cited by 46
Zhang, H., Wu, S., & Xing, D. (2011) · APOPTOSIS · doi:10.1007/s10495-011-0608-y · Cited by 47
Recent Advances in Targeting Transition Metals (Copper, Iron, and Zinc) in Alzheimer’s Disease
Singh, R., Panghal, A., Jadhav, K., Thakur, A., Verma, R. K., Singh, C., Goyal, M., Kumar, J., & Namdeo, A. G. (2024) · Molecular Neurobiology · doi:10.1007/s12035-024-04256-8 · Cited by 50
Pascual, A. C., Martín-Moreno, A. M., Giusto, N. M., CEBALLOS, M. L. D., & Pasquaré, S. J. (2014) · Experimental Gerontology · doi:10.1016/j.exger.2014.10.011 · Cited by 46
Aβ-AGE aggravates cognitive deficit in rats via RAGE pathway
Chen, C., Li, X.-H., Tu, Y., Sun, H.-T., Liang, H., Cheng, S., & Zhang, S. (2013) · Neuroscience · doi:10.1016/j.neuroscience.2013.10.056 · Cited by 46
Fang, F., & Liu, G.-T. (2006) · Acta Pharmacologica Sinica · doi:10.1111/j.1745-7254.2006.00347.x · Cited by 46
dos Santos, J. P. A., Vizuete, A. F. K., Hansen, F., Biasibetti, R., & Gonçalves, C. (2017) · Journal of Alzheimer s Disease · doi:10.3233/jad-170211 · Cited by 46
Cecarini, V., Bonfili, L., Amici, M., Angeletti, M., Keller, J. N., & Eleuteri, A. M. (2008) · Brain Research · doi:10.1016/j.brainres.2008.03.003 · Cited by 46
Bartov, O., Rukhsana Sultana, A., Butterfield, D. A., & Atlas, D. (2006) · Brain Research · doi:10.1016/j.brainres.2005.10.079 · Cited by 46
Singh, N. K., & Garabadu, D. (2021) · Neurotoxicity Research · doi:10.1007/s12640-021-00410-5 · Cited by 45
RetractedFerrera, P., Mercado-Gómez, O. F., Silva-Aguilar, M., Valverde, M., & Arias, C. (2008) · Neurochemical Research · doi:10.1007/s11064-008-9623-y · Cited by 46
Thangnipon, W., Suwanna, N., Kitiyanant, N., Soi‐ampornkul, R., Tuchinda, P., Munyoo, B., & Nobsathian, S. (2012) · Neuroscience Letters · doi:10.1016/j.neulet.2012.02.047 · Cited by 45
Galanthamine decreases genotoxicity and cell death induced by β-amyloid peptide in SH-SY5Y cell line
Ordoñez, W. O. C., Aristizábal-Pachón, A. F., Montaldi, A. P. D. L., Sakamoto‐Hojo, E. T., & Takahashi, C. S. (2016) · NeuroToxicology · doi:10.1016/j.neuro.2016.10.013 · Cited by 43
Androgens, ApoE, and Alzheimer's Disease
Raber, J. (2004) · Science of Aging Knowledge Environment · doi:10.1126/sageke.2004.11.re2 · Cited by 48
Endothelial leakiness elicited by amyloid protein aggregation
Li, Y., Ni, N., Lee, M., Wei, W., Andrikopoulos, N., Käkinen, A., Davis, T. P., Song, Y., Ding, F., Leong, D. T., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-44814-1 · Cited by 52
Thummayot, S., Tocharus, C., Pinkaew, D., Viwatpinyo, K., Sringarm, K., & Tocharus, J. (2014) · NeuroToxicology · doi:10.1016/j.neuro.2014.10.010 · Cited by 44
Wang, H., Dharmalingam, P., Vasquez, V., Mitra, J., Boldogh, I. R., Rao, K. S. J., Kent, T. A., MITRA, S. P., & Hegde, M. L. (2016) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2016.09.005 · Cited by 46
Châari, A. (2020) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2020.06.170 · Cited by 44
Misiti, F., Clementi, M. E., & Giardina, B. (2010) · Neurochemistry International · doi:10.1016/j.neuint.2010.01.002 · Cited by 44
Koh, E.-J., Kim, K.-J., Choi, J., Kang, D.-H., & Lee, B.-Y. (2018) · Neuroscience Letters · doi:10.1016/j.neulet.2018.02.057 · Cited by 43
Chilton, P. M., Ghare, S. S., Charpentier, B. T., Myers, S., Rao, A. V., Petrosino, J. F., Hoffman, K. L., Greenwell, J. C., Tyagi, N., Behera, J., et al. (2024) · Gut Microbes · doi:10.1080/19490976.2024.2389319 · Cited by 45
Rao, K. V. R., Curtis, K. M., Johnstone, J. T., & Norenberg, M. D. (2013) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e31829bd082 · Cited by 43
Moongkarndi, P., Srisawat, C., Saetun, P., Jantaravinid, J., Peerapittayamongkol, C., Soi‐ampornkul, R., Junnu, S., Sinchaikul, S., Chen, S., Charoensilp, P., et al. (2010) · Journal of Proteome Research · doi:10.1021/pr100049v · Cited by 43
Adav, S. S., & Sze, S. K. (2020) · Aging and Disease · doi:10.14336/ad.2019.0604 · Cited by 44
Mezeiová, E., Janočková, J., Andrýs, R., Soukup, O., Kobrlová, T., Múčková, Ľ., Pejchal, J., Šimunková, M. M., Handl, J., Micankova, P., et al. (2020) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2020.113112 · Cited by 42
Chiang, M., Nicol, C. J. B., Lin, C., Chen, S., Yen, C., & Huang, R. (2021) · Neurochemistry International · doi:10.1016/j.neuint.2021.104992 · Cited by 44
Ma, Q., Ruan, Y., Xu, H. Y., Shi, X., Wang, Z., & Hu, Y. (2015) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2015.10.004 · Cited by 43
Diterpenes: Advances in Neurobiological Drug Research
Islam, M. T., da Silva, C. B., de Alencar, M. V. O. B., Paz, M. F. C. J., Almeida, F. R. D. C., & Cavalcante, A. A. D. C. M. (2016) · Phytotherapy Research · doi:10.1002/ptr.5609 · Cited by 42
Disturbances in the control of capillary flow in an aged APPswe/PS1ΔE9 model of Alzheimer's disease
Gutiérrez‐Jiménez, E., Angleys, H., Rasmussen, P. M., West, M. J., Catalini, L., Iversen, N., Jensen, M. S., Frische, S., & Østergaard, L. (2017) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2017.10.006 · Cited by 44
Stress and Alzheimer’s disease
Escher, C. M., Sannemann, L., & Jessen, F. (2019) · Journal of Neural Transmission · doi:10.1007/s00702-019-01988-z · Cited by 47
Medina, M. E., Galano, A., & Alvarez-Idaboy, J. R. (2013) · Physical Chemistry Chemical Physics · doi:10.1039/c3cp53889c · Cited by 42
Medina, M. E., Iuga, C., & Alvarez-Idaboy, J. R. (2014) · RSC Advances · doi:10.1039/c4ra08394f · Cited by 42
Hunter, S., Arendt, T., & Brayne, C. (2013) · Molecular Neurobiology · doi:10.1007/s12035-013-8445-3 · Cited by 41
Details of the antioxidant mechanism of hydroxycinnamic acids
Shang, Y., Liu, B.-Y., & Zhao, M. (2015) · Czech Journal of Food Sciences · doi:10.17221/611/2014-cjfs · Cited by 41
Maronić, D. Š., Čamagajevac, I. Š., Horvatić, J., Pfeiffer, T. Ž., Stević, F., Žarković, N., Waeg, G., & Jaganjac, M. (2018) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2018.04.433 · Cited by 41
Role of selenoprotein P in Alzheimer's disease.
Takemoto, A. S., Berry, M. J., & Bellinger, F. P. (2010) · PubMed · Cited by 41
Lee, Y. K., Choi, I. S., Ban, J. O., Lee, H. J., Lee, U. S., Han, S., Jung, J., Kim, Y. H., Kim, K. H., Oh, K., et al. (2010) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2010.04.002 · Cited by 41
Lange, M. L. B., Clair, D. K. S., Markesbery, W. R., Studzinski, C. M., Murphy, M. P., & Butterfield, D. A. (2010) · Neurobiology of Disease · doi:10.1016/j.nbd.2010.01.004 · Cited by 41
Neuroprotective Effects of PARP Inhibitors in Drosophila Models of Alzheimer’s Disease
Maggiore, A., Casale, A. M., Toscanelli, W., Cappucci, U., Rotili, D., Grieco, M., Gagné, J.-P., Poirier, G. G., d’Erme, M., & Piacentini, L. (2022) · Cells · doi:10.3390/cells11081284 · Cited by 40
Mao, Y., Zhang, L., Zhang, C., Qin, L., Liao, X., & Zhao, L. (2025) · Journal of Trace Elements in Medicine and Biology · doi:10.1016/j.jtemb.2025.127692 · Cited by 43
Roy, S. S., & Rauk, A. (2005) · Medical Hypotheses · doi:10.1016/j.mehy.2004.08.031 · Cited by 38
The Cys Sense: Thiol Redox Switches Mediate Life Cycles of Cellular Proteins
Radzinski, M., Oppenheim, T., Metanis, N., & Reichmann, D. (2021) · Biomolecules · doi:10.3390/biom11030469 · Cited by 38
Recuero, M., Vicente, M. C., Martı́nez-Garcı́a, A., Ramos, M. C., Carmona‐Sáez, P., Sastre, I., Aldudo, J., Vilella, E., Frank, A., Bullido, M. J., et al. (2009) · Aging Cell · doi:10.1111/j.1474-9726.2009.00457.x · Cited by 42
Mota, S. I., Ferreira, I. L., Pereira, C., Oliveira, C. R., & Rego, A. C. (2012) · Current Alzheimer Research · doi:10.2174/156720512802455322 · Cited by 42
Price, K. A., Caragounis, A., Paterson, B. M., Filiz, G., Volitakis, I., Masters, C. L., Barnham, K. J., Donnelly, P. S., Crouch, P. J., & White, A. R. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm9007938 · Cited by 40
Triplett, J. C., Swomley, A. M., Cai, J., Klein, J. B., & Butterfield, D. A. (2015) · Journal of Alzheimer s Disease · doi:10.3233/jad-150417 · Cited by 40
Feng, S., Zhao, T., Hai‐Meng, Z. H. O. U., & Yan, Y. (2006) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2006.09.004 · Cited by 39
Amiri, M., Braidy, N., & Aminzadeh, M. (2018) · Neurotoxicity Research · doi:10.1007/s12640-018-9914-2 · Cited by 38
Manukhina, E. B., Goryacheva, A. V., Barskov, I. V., Викторов, И. В., Guseva, A. A., Pshennikova, M. G., Khomenko, I. P., Mashina, S. Y., Pokidyshev, D. A., & Malyshev, I. Y. (2010) · Neuroscience and Behavioral Physiology · doi:10.1007/s11055-010-9320-6 · Cited by 41
The Dying of the Light: Mitochondrial Failure in Alzheimer's Disease
Young, K. J., McArdle, M. J., & Bennett, J. P. (2012) · Journal of Alzheimer s Disease · doi:10.3233/jad-2011-111487 · Cited by 39
Fernàndez‐Busquets, X., Ponce, J., Bravo, R., Arimon, M., Martiáñez, T., Gella, A., Cladera, J., & Durany, N. (2010) · Current Alzheimer Research · doi:10.2174/156720510791383787 · Cited by 38
Park, H., Kang, S., Nam, E., Suh, Y., & Chang, K. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.00002 · Cited by 38
Andrés, C. M. C., de la Lastra, J. M. P., Andrés, C., Plou, F. J., & Pérez‐Lebeña, E. (2023) · Journal of Biochemical and Molecular Toxicology · doi:10.1002/jbt.23455 · Cited by 44
Woltjer, R. L., McMahan, W., Milatović, D., Kjerulf, J. D., Shie, F., Rung, L. G., Montine, K. S., & Montine, T. J. (2006) · Neurobiology of Disease · doi:10.1016/j.nbd.2006.10.003 · Cited by 38
Mehranfard, N., Ghasemi, M., Rajabian, A., & Ansari, L. (2023) · Heliyon · doi:10.1016/j.heliyon.2023.e22820 · Cited by 40
Kalmankar, N. V., Hari, H., Sowdhamini, R., & Venkatesan, R. (2021) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.1c00033 · Cited by 37
Hyperhomocysteinemia in Alzheimer's Disease: The Hen and the Egg?
Farkas, M., Keskitalo, S., Smith, D. E. C., Bain, N., Semmler, A., Ineichen, B. V., Smulders, Y. M., Blom, H. J., Kulic, L., & Linnebank, M. (2013) · Journal of Alzheimer s Disease · doi:10.3233/jad-2012-121378 · Cited by 36
Pramanik, D., Sengupta, K., Mukherjee, S., Dey, S. G., & Dey, A. (2012) · Journal of the American Chemical Society · doi:10.1021/ja303930f · Cited by 36
Komatsu, H., Liu, L., Murray, I. V. J., & Axelsen, P. H. (2007) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2007.05.026 · Cited by 36
Chalimoniuk, M., Stolecka‐Warzecha, A., Cąkała, M., Hauptmann, S., Schulz, K., Lipka, U., Leuner, K., Eckert, A., Muller, W. E., & Strosznajder, J. B. (2007) · Acta Biochimica Polonica · doi:10.18388/abp.2007_3235 · Cited by 35
Docosahexaenoic acid withstands the Aβ25-35-induced neurotoxicity in SH-SY5Y cells
Hashimoto, M., Katakura, M., Hossain, S., Rahman, A., Shimada, T., & Shido, O. (2010) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2009.11.005 · Cited by 36
Vangavaragu, J. R., Valasani, K. R., Gan, X., & Yan, S. S. (2014) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2014.02.046 · Cited by 35
Tan, L., Yang, H., Pang, W., Li, H., Liu, W., Sun, S., Song, N., Zhang, W., & Jiang, Y. (2016) · Journal of Alzheimer s Disease · doi:10.3233/jad-151108 · Cited by 35
Kantar, D., Hidişoğlu, E., Ocak, G. A., Er, H., Acun, A. D., & Yargıçoğlu, P. (2018) · Neurochemistry International · doi:10.1016/j.neuint.2018.04.008 · Cited by 34
Metadata
- Authors
- Allan Butterfield, D.
- Venue
- Free Radical Research
- Publisher
- Informa UK Limited
- Published
- 2002-01
- Volume
- 36
- Issue
- 12
- Pages
- 1307-1313
- ISSN
- 1029-2470 (ISSN-L)
- 1071-5762
- OpenAlex
- W2153767421
- Cited by
- 786
- References
- 58
- Citations by year
- 2026: 12 · 2025: 20 · 2024: 18 · 2023: 21 · 2022: 24 · 2021: 34 · 2020: 26 · 2019: 28 · 2018: 30 · 2017: 32 · 2016: 45 · 2015: 43 · 2014: 42 · 2013: 39 · 2012: 42
- FWCI
- 18.78
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Free Radical Research (publishedVersion)
- PubMed (publishedVersion)
- Funders
- University of Kentucky
- National Institute on Aging (P01AG010836, P01AG005119, AG 10836, AG12423, AG0 5119, R01AG012423)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Keywords
- amyloid beta peptide 1-42, oxidative stress, neurotoxicity, Alzheimer's disease, protein oxidation, lipid peroxidation, nitrotyrosine, vitamin E, hippocampal neurons, synaptosomes, apolipoprotein E, APOE ε4, amyloid fibril formation, neurodegeneration, lipid bilayers
- MeSH terms
- Alzheimer Disease, Amino Acid Sequence, Animals, Brain, Humans, Lipid Bilayers, Methionine, Molecular Sequence Data, Neurons, Peptide Fragments, Peptides, Free Radical Scavengers, Amyloid beta-Peptides, Reactive Oxygen Species, Protein Structure, Tertiary, Oxidative Stress
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review